The FDA approved Moderna’s mFlusiva, America’s first mRNA flu vaccine, for adults 50 and older. Here’s how its approval and effectiveness differ by age.

Updated 2025-2026 formulations of mRNA-1283 and BNT162b2 protect older adults against severe COVID-19 outcomes and medically attended illness.

Older adults who received the latest COVID-19 vaccine were significantly less likely to suffer serious heart-related complications, according to a major new study involving more than 1 million U ...

Known as Xocova, this is a once-daily pill that helps prevent the virus after exposure. When taken as prescribed, Xocova can reduce the likelihood of developing Covid-19 symptoms by 67%, according to ...

The American College of Physicians (ACP) has recommended that adults aged 65 years or older receive updated 2025–2026 mRNA-based COVID-19 vaccines, according to February guidelines published in ...

Adults 65 years and older are disproportionately impacted by COVID-19 and at higher risk for severe disease and hospitalizations. “Today’s recommendation allows older adults to receive an ...

Experts say COVID-19 should not be dismissed as just another seasonal flu. While widespread immunity has reduced the severity of infection, the virus continues to hospitalise and kill vulnerable ...

The COVID-19 pandemic has exerted profound and multifaceted effects on the mental health of older adults worldwide. Widespread lockdowns and social-distancing measures heightened social ...